Blind Stargardt patient reads a letter again after PRIMA implant in Science clinical trial
lukaszkaiser · x · 2026-09-25
Science Corp reports that a patient legally blind from Stargardt disease — which destroys central vision with no existing treatment — saw a letter again during his first rehabilitation session after receiving the PRIMA implant in a clinical trial.
PRIMA is already approved in Europe for geographic atrophy; the trial now extends it to Stargardt disease and retinitis pigmentosa patients.
More from AGI Musings
- Ross Girshick posts CVPR slides recounting 1.5 decades of object detection and its link to the LLM era — CatAstro_Piyush · 2026-11-11
- Ben Todd wrestles with a 50:50 chance only 18 months remain of 'the human era' — ben_j_todd · 2026-11-11
- Mathematicians face identity crisis as AI solves problems in hours, Corriere interview warns — ValerioCapraro · 2026-11-11
- Why inference speed will be AI products' biggest competitive edge in 1–2 years — itsOmSarraf_ · 2026-11-11
- AI Defense Shifts to Scale Economics: Attacks Buried in Legitimate Traffic — DavidLinthicum · 2026-11-11
- Ben Todd's alt log-log plot shows task horizons hitting a singularity in under 12 months — ben_j_todd · 2026-11-11